Literature DB >> 7514276

Translational regulation of nanos by RNA localization.

E R Gavis1, R Lehmann.   

Abstract

Localization of the maternally synthesized nanos (nos) RNA to the posterior pole of the Drosophila embryo provides the source for a posterior-to-anterior gradient of Nos protein. Correct spatial regulation of nos activity is essential for normal pattern formation. High local concentrations of Nos protein in the posterior of the embryo are necessary to inhibit translation of the transcription factor Hunchback in this region, and thus permit expression of genes required for abdomen formation (see ref. 5 for review). By contrast, misexpression of Nos protein at the anterior of the embryo prevents translation of the anterior morphogen Bicoid, suppressing head and thorax development. Posterior localization of nos RNA is mediated by sequences within the nos 3' untranslated region (3'UTR) and requires the function of eight genes of the 'posterior group'. Although the unlocalized nos RNA is stable in embryos from females mutant for any of the posterior group genes, these embryos appear to lack nos activity because they develop the abdominal defects characteristic of embryos produced by nos mutant females. We report here that unlocalized nos RNA is translationally repressed. Translational repression is mediated by the nos 3'UTR and can be alleviated either by replacement of the 3'UTR with heterologous 3'UTR sequences or by posterior localization. Thus, RNA localization provides a novel mechanism for translational regulation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7514276     DOI: 10.1038/369315a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  93 in total

1.  Quantitative analysis of gene function in the Drosophila embryo.

Authors:  W D Tracey; X Ning; M Klingler; S G Kramer; J P Gergen
Journal:  Genetics       Date:  2000-01       Impact factor: 4.562

2.  Joint action of two RNA degradation pathways controls the timing of maternal transcript elimination at the midblastula transition in Drosophila melanogaster.

Authors:  A Bashirullah; S R Halsell; R L Cooperstock; M Kloc; A Karaiskakis; W W Fisher; W Fu; J K Hamilton; L D Etkin; H D Lipshitz
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

3.  Coordinate control of translation and localization of Vg1 mRNA in Xenopus oocytes.

Authors:  J E Wilhelm; R D Vale; R S Hegde
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

Review 4.  Cytoplasmic polyadenylation in development and beyond.

Authors:  J D Richter
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

5.  Evidence for involvement of 3'-untranslated region in determining angiotensin II receptor coupling specificity to G-protein.

Authors:  Thomas J Thekkumkara; Stuart L Linas
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

6.  From cis-regulatory elements to complex RNPs and back.

Authors:  Fátima Gebauer; Thomas Preiss; Matthias W Hentze
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-07-01       Impact factor: 10.005

Review 7.  Nanos genes and their role in development and beyond.

Authors:  Evi De Keuckelaere; Paco Hulpiau; Yvan Saeys; Geert Berx; Frans van Roy
Journal:  Cell Mol Life Sci       Date:  2018-02-03       Impact factor: 9.261

8.  Drosophila Cup is an eIF4E-binding protein that functions in Smaug-mediated translational repression.

Authors:  Meryl R Nelson; Andrew M Leidal; Craig A Smibert
Journal:  EMBO J       Date:  2003-12-11       Impact factor: 11.598

9.  Further analysis of cytoplasmic polyadenylation in Xenopus embryos and identification of embryonic cytoplasmic polyadenylation element-binding proteins.

Authors:  R Simon; J D Richter
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

10.  An essential role of DmRad51/SpnA in DNA repair and meiotic checkpoint control.

Authors:  Eric Staeva-Vieira; Siuk Yoo; Ruth Lehmann
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.